These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21159499)

  • 41. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
    Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E
    Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trial.
    Tashkin D; Celli B; Kesten S; Lystig T; Decramer M
    Respir Med; 2010 Oct; 104(10):1495-504. PubMed ID: 20418083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.
    Tashkin DP; Littner M; Andrews CP; Tomlinson L; Rinehart M; Denis-Mize K
    Respir Med; 2008 Apr; 102(4):479-87. PubMed ID: 18258423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of tiotropium inhalation powder in african-american patients with chronic obstructive pulmonary disease.
    Criner GJ; Sharafkhaneh A; Player R; Conoscenti CS; Johnson P; Keyser MT; Cassino C
    COPD; 2008 Feb; 5(1):35-41. PubMed ID: 18259973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease].
    Zheng JP; Kang J; Cai BQ; Zhou X; Cao ZL; Bai CX; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):363-7. PubMed ID: 17045014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD.
    Cazzola M; Andò F; Santus P; Ruggeri P; Di Marco F; Sanduzzi A; D'Amato M
    Pulm Pharmacol Ther; 2007; 20(5):556-61. PubMed ID: 16914336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease.
    Lee JS; Huh JW; Chae EJ; Seo JB; Ra SW; Lee JH; Kim EK; Lee YK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Oh YM; Lee SD
    Clin Physiol Funct Imaging; 2012 Jan; 32(1):12-8. PubMed ID: 22152074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease.
    Chan CK; Maltais F; Sigouin C; Haddon JM; Ford GT;
    Can Respir J; 2007; 14(8):465-72. PubMed ID: 18060091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multidetector-row computed tomography assessment of adding budesonide/formoterol to tiotropium in patients with chronic obstructive pulmonary disease.
    Yasui H; Inui N; Furuhashi K; Nakamura Y; Uto T; Sato J; Yasuda K; Takehara Y; Suda T; Chida K
    Pulm Pharmacol Ther; 2013 Jun; 26(3):336-41. PubMed ID: 23340058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD.
    Briggs DD; Covelli H; Lapidus R; Bhattycharya S; Kesten S; Cassino C
    Pulm Pharmacol Ther; 2005; 18(6):397-404. PubMed ID: 16179215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease.
    Verkindre C; Bart F; Aguilaniu B; Fortin F; Guérin JC; Le Merre C; Iacono P; Huchon G
    Respiration; 2006; 73(4):420-7. PubMed ID: 16484769
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies.
    Bateman E; Singh D; Smith D; Disse B; Towse L; Massey D; Blatchford J; Pavia D; Hodder R
    Int J Chron Obstruct Pulmon Dis; 2010 Aug; 5():197-208. PubMed ID: 20714373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.
    van Noord JA; Cornelissen PJ; Aumann JL; Platz J; Mueller A; Fogarty C
    Respir Med; 2009 Jan; 103(1):22-9. PubMed ID: 19022642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of tiotropium on lung function in severe asthmatics with or without emphysematous changes.
    Yoshida M; Nakano T; Fukuyama S; Matsumoto T; Eguchi M; Moriwaki A; Takata S; Machida K; Kanaya A; Matsumoto K; Nakanishi Y; Inoue H
    Pulm Pharmacol Ther; 2013 Apr; 26(2):159-66. PubMed ID: 23073336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease.
    Fujimoto K; Kitaguchi Y; Kanda S; Urushihata K; Hanaoka M; Kubo K
    Int J Chron Obstruct Pulmon Dis; 2011; 6():219-27. PubMed ID: 21660299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.
    Troosters T; Celli B; Lystig T; Kesten S; Mehra S; Tashkin DP; Decramer M;
    Eur Respir J; 2010 Jul; 36(1):65-73. PubMed ID: 20185426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tiotropium improves walking endurance in COPD.
    Bédard ME; Brouillard C; Pepin V; Provencher S; Milot J; Lacasse Y; Leblanc P; Maltais F
    Eur Respir J; 2012 Feb; 39(2):265-71. PubMed ID: 21700602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients.
    Ichinose M; Fujimoto T; Fukuchi Y
    Respir Med; 2010 Feb; 104(2):228-36. PubMed ID: 19969446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD.
    Tashkin DP; Donohue JF; Mahler DA; Huang H; Goodwin E; Schaefer K; Hanrahan JP; Andrews WT
    Respir Med; 2009 Apr; 103(4):516-24. PubMed ID: 19208459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treadmill endurance during 2-year treatment with tiotropium in patients with COPD: a randomized trial.
    Cooper CB; Celli BR; Jardim JR; Wise RA; Legg D; Guo J; Kesten S
    Chest; 2013 Aug; 144(2):490-497. PubMed ID: 23558890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.